

Search here
Categories
Recent Posts
Anaveon announces presentation of a novel development compound at the 2023 American Association for Cancer Research Annual Meeting
March 23, 2023Anaveon announces first patient dosed with ANV419 in a Phase I/II Study of ANV419 in patients with multiple myeloma
March 16, 2023Anaveon doses first patient in a Phase I/II Study of ANV419 as monotherapy or in combination with check point inhibitors in patients with advanced melanoma
February 2, 2023
Popular Tags
Archives
- March 2023 2
- February 2023 1
- November 2022 2
- October 2022 1
- September 2022 1
- July 2022 3
- April 2022 1
- March 2022 1
- December 2021 1
- November 2021 1
- June 2021 1
- March 2021 1
- November 2020 1
- May 2020 1
- April 2019 1
- February 2019 1